FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085754069> ?p ?o ?g. }

• W2085754069 endingPage "84" @default.
• W2085754069 startingPage "73" @default.
• W2085754069 abstract "Recombinant Chinese hamster ovary (CHO) cells expressing a high-level of chimeric antibody against S surface antigen of hepatitis B virus were obtained by co-transfection of heavy and light chain cDNA expression vectors into dihydrofolate reductase (dhfr)-deficient CHO cells and subsequent gene amplification in medium containing stepwise increments in methotrexate (MTX) level such as 0.02, 0.08, 0.32, 1.0, and 4.0 μM. The highest producer (HP) subclone was isolated from each MTX level and was characterized with respect to cell growth and antibody production in the corresponding level of MTX. The specific growth rate of the HP subclone was inversely proportional to the MTX level. On the other hand, its specific antibody productivity (qAb) rapidly increased with increasing MTX level up to 0.08 μM, and thereafter, it gradually increased to 20 μg/106 cells/day at 4 μM MTX. Southern blot analysis showed that the enhanced qAb at higher MTX level resulted from immunoglobulin (Ig) gene amplification. The stability of the HP subclones isolated at 0.02, 0.08, 0.32, and 1.0 μM MTX in regard to antibody production was investigated during long-term culture in the absence of MTX. The qAb of all subclones significantly decreased during the culture. However, the relative extent of decrease in qAb was variable among the subclones. The HP subclone isolated at 1 μM MTX was most stable and could retain 59% of the initial qAb after 80 days of cultivation. Southern blot analysis showed that this decrease in qAb of the subclones resulted mainly from the loss of Ig gene copies during long-term culture. Despite the decreased qAb, the HP subclone isolated at 1 μM MTX could maintain high volumetric antibody productivity over three months because of improved cell growth rate during long-term culture. © 1998 John Wiley & Sons, Inc. Biotechnol Bioeng 58:73–84, 1998." @default.
• W2085754069 created "2016-06-24" @default.
• W2085754069 creator A5020967749 @default.
• W2085754069 creator A5034334667 @default.
• W2085754069 creator A5040136802 @default.
• W2085754069 creator A5046424925 @default.
• W2085754069 creator A5077862555 @default.
• W2085754069 date "1998-04-05" @default.
• W2085754069 modified "2023-10-17" @default.
• W2085754069 title "Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure" @default.
• W2085754069 cites W1588080030 @default.
• W2085754069 cites W1970296191 @default.
• W2085754069 cites W1971085275 @default.
• W2085754069 cites W1971956129 @default.
• W2085754069 cites W2013110336 @default.
• W2085754069 cites W2017609679 @default.
• W2085754069 cites W2017949868 @default.
• W2085754069 cites W2029365183 @default.
• W2085754069 cites W2042455517 @default.
• W2085754069 cites W2043719699 @default.
• W2085754069 cites W2044019412 @default.
• W2085754069 cites W2057058036 @default.
• W2085754069 cites W2065386076 @default.
• W2085754069 cites W2068347130 @default.
• W2085754069 cites W2072452270 @default.
• W2085754069 cites W2078098552 @default.
• W2085754069 cites W2080665724 @default.
• W2085754069 cites W2082010047 @default.
• W2085754069 cites W2108084139 @default.
• W2085754069 cites W2140032109 @default.
• W2085754069 cites W2168052342 @default.
• W2085754069 cites W2170618025 @default.
• W2085754069 cites W651145451 @default.
• W2085754069 doi "https://doi.org/10.1002/(sici)1097-0290(19980405)58:1<73::aid-bit8>3.0.co;2-r" @default.
• W2085754069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10417224" @default.
• W2085754069 hasPublicationYear "1998" @default.
• W2085754069 type Work @default.
• W2085754069 sameAs 2085754069 @default.
• W2085754069 citedByCount "187" @default.
• W2085754069 countsByYear W20857540692012 @default.
• W2085754069 countsByYear W20857540692013 @default.
• W2085754069 countsByYear W20857540692014 @default.
• W2085754069 countsByYear W20857540692015 @default.
• W2085754069 countsByYear W20857540692016 @default.
• W2085754069 countsByYear W20857540692017 @default.
• W2085754069 countsByYear W20857540692018 @default.
• W2085754069 countsByYear W20857540692019 @default.
• W2085754069 countsByYear W20857540692020 @default.
• W2085754069 countsByYear W20857540692021 @default.
• W2085754069 countsByYear W20857540692022 @default.
• W2085754069 countsByYear W20857540692023 @default.
• W2085754069 crossrefType "journal-article" @default.
• W2085754069 hasAuthorship W2085754069A5020967749 @default.
• W2085754069 hasAuthorship W2085754069A5034334667 @default.
• W2085754069 hasAuthorship W2085754069A5040136802 @default.
• W2085754069 hasAuthorship W2085754069A5046424925 @default.
• W2085754069 hasAuthorship W2085754069A5077862555 @default.
• W2085754069 hasConcept C104317684 @default.
• W2085754069 hasConcept C147483822 @default.
• W2085754069 hasConcept C153911025 @default.
• W2085754069 hasConcept C159654299 @default.
• W2085754069 hasConcept C175656101 @default.
• W2085754069 hasConcept C203014093 @default.
• W2085754069 hasConcept C2776415932 @default.
• W2085754069 hasConcept C2781320022 @default.
• W2085754069 hasConcept C40767141 @default.
• W2085754069 hasConcept C54009773 @default.
• W2085754069 hasConcept C54355233 @default.
• W2085754069 hasConcept C55493867 @default.
• W2085754069 hasConcept C81885089 @default.
• W2085754069 hasConcept C86803240 @default.
• W2085754069 hasConceptScore W2085754069C104317684 @default.
• W2085754069 hasConceptScore W2085754069C147483822 @default.
• W2085754069 hasConceptScore W2085754069C153911025 @default.
• W2085754069 hasConceptScore W2085754069C159654299 @default.
• W2085754069 hasConceptScore W2085754069C175656101 @default.
• W2085754069 hasConceptScore W2085754069C203014093 @default.
• W2085754069 hasConceptScore W2085754069C2776415932 @default.
• W2085754069 hasConceptScore W2085754069C2781320022 @default.
• W2085754069 hasConceptScore W2085754069C40767141 @default.
• W2085754069 hasConceptScore W2085754069C54009773 @default.
• W2085754069 hasConceptScore W2085754069C54355233 @default.
• W2085754069 hasConceptScore W2085754069C55493867 @default.
• W2085754069 hasConceptScore W2085754069C81885089 @default.
• W2085754069 hasConceptScore W2085754069C86803240 @default.
• W2085754069 hasIssue "1" @default.
• W2085754069 hasLocation W20857540691 @default.
• W2085754069 hasLocation W20857540692 @default.
• W2085754069 hasOpenAccess W2085754069 @default.
• W2085754069 hasPrimaryLocation W20857540691 @default.
• W2085754069 hasRelatedWork W2057291960 @default.
• W2085754069 hasRelatedWork W2083274803 @default.
• W2085754069 hasRelatedWork W2180821465 @default.
• W2085754069 hasRelatedWork W2359175313 @default.
• W2085754069 hasRelatedWork W2367939407 @default.
• W2085754069 hasRelatedWork W2369736488 @default.
• W2085754069 hasRelatedWork W2370770352 @default.
• W2085754069 hasRelatedWork W2378943006 @default.

• next